Valeant Pharmaceuticals (VRX) volatility spikes into Q3 and outlook

November 1, 2016 12:30 PM EDT

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Valeant Pharmaceuticals (VRX) 11/4 call option implied volatility is at 92, 11/11 s at 161; compared to its 52-week range of 53 to 173 into the expected release of Q3 results next week.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment